AAAAAA

   
Results: 1-25 | 26-32
Results: 1-25/32

Authors: MARTH C TROPE C VERGOTE IB KRISTENSEN GB
Citation: C. Marth et al., 10-YEAR RESULTS OF A RANDOMIZED TRIAL COMPARING CISPLATIN WITH CISPLATIN AND CYCLOPHOSPHAMIDE IN ADVANCED, SUBOPTIMALLY DEBULKED OVARIAN-CANCER, European journal of cancer, 34(8), 1998, pp. 1175-1180

Authors: SCHULERUD H KRISTENSEN GB LIESTOL K VLATKOVIC L REITH A ALBREGTSEN F DANIELSEN HE
Citation: H. Schulerud et al., A REVIEW OF CAVEATS IN STATISTICAL NUCLEAR IMAGE-ANALYSIS, Analytical cellular pathology, 16(2), 1998, pp. 63-82

Authors: HOFSTRA LS KRISTENSEN GB WILLEMSE PHB VINDEVOGHEL A MEDEN H LAHOUSEN M OBERLING F SORBE B CRUMP M SKLENAR I SLUITER WJ KIESE B TROPE CG DEVRIES EGE
Citation: Ls. Hofstra et al., RANDOMIZED TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-3 VERSUS PLACEBO INPREVENTION OF BONE-MARROW DEPRESSION DURING FIRST-LINE CHEMOTHERAPY FOR OVARIAN-CARCINOMA, Journal of clinical oncology, 16(10), 1998, pp. 3335-3344

Authors: NORDAL RR KRISTENSEN GB STENWIG AE TROPE CG NESLAND JM
Citation: Rr. Nordal et al., IMMUNOHISTOCHEMICAL ANALYSIS OF P53 PROTEIN IN UTERINE SARCOMAS, Gynecologic oncology (Print), 70(1), 1998, pp. 45-48

Authors: KRISTENSEN GB TROPE C
Citation: Gb. Kristensen et C. Trope, EPITHELIAL OVARIAN-CARCINOMA, Lancet, 349(9045), 1997, pp. 113-117

Authors: NORDAL RR KRISTENSEN GB STENWIG AE NESLAND JM PETTERSEN EO TROPE CG
Citation: Rr. Nordal et al., AN EVALUATION OF PROGNOSTIC FACTORS IN UTERINE CARCINOSARCOMA, Gynecologic oncology, 67(3), 1997, pp. 316-321

Authors: SKOMEDAL H KRISTENSEN GB ABELER VM BORRESENDALE AL TROPE C HOLM R
Citation: H. Skomedal et al., TP53 PROTEIN ACCUMULATION AND GENE MUTATION IN RELATION TO OVEREXPRESSION OF MDM2 PROTEIN IN OVARIAN BORDERLINE TUMORS AND STAGE-I CARCINOMAS, Journal of pathology, 181(2), 1997, pp. 158-165

Authors: HELLAND A BORRESENDALE AL PELTOMAKI P HEKTOEN M KRISTENSEN GB NESLAND JM DELACHAPELLE A LOTHE RA
Citation: A. Helland et al., MICROSATELLITE INSTABILITY IN CERVICAL AND ENDOMETRIAL CARCINOMAS, International journal of cancer, 70(5), 1997, pp. 499-501

Authors: KRISTENSEN GB KARLSEN F JENKINS A KAERN J ABELER VM TROPE CG
Citation: Gb. Kristensen et al., HUMAN PAPILLOMA-VIRUS HAS NO PROGNOSTIC-SIGNIFICANCE IN CERVICAL-CARCINOMA, European journal of cancer, 32A(8), 1996, pp. 1349-1353

Authors: DORUM A KRISTENSEN GB ABELER VM TROPE CG MOLLER P
Citation: A. Dorum et al., EARLY DETECTION OF FAMILIAL OVARIAN-CANCER, European journal of cancer, 32A(10), 1996, pp. 1645-1651

Authors: NORDAL RR KRISTENSEN GB KAERN J STENWIG AE PETTERSEN EO TROPE CG
Citation: Rr. Nordal et al., THE PROGNOSTIC-SIGNIFICANCE OF SURGERY, TUMOR SIZE, MALIGNANCY GRADE,MENOPAUSAL STATUS, AND DNA-PLOIDY IN ENDOMETRIAL STROMAL SARCOMA, Gynecologic oncology, 62(2), 1996, pp. 254-259

Authors: KRISTENSEN GB HOLM R ABELER VM TROPE CG
Citation: Gb. Kristensen et al., EVALUATION OF THE PROGNOSTIC-SIGNIFICANCE OF NM23 NDP KINASE PROTEIN EXPRESSION IN CERVICAL-CARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY/, Gynecologic oncology, 61(3), 1996, pp. 378-383

Authors: SCHEISTROEN M TROPE C KAERN J ABELER VM PETTERSEN EO KRISTENSEN GB
Citation: M. Scheistroen et al., MALIGNANT-MELANOMA OF THE VULVA FIGO STAGE-I - EVALUATION OF PROGNOSTIC FACTORS IN 43 PATIENTS WITH EMPHASIS ON DNA-PLOIDY AND SURGICAL-TREATMENT, Gynecologic oncology, 61(2), 1996, pp. 253-258

Authors: KAERN J TROPE C SUNDFOER K KRISTENSEN GB
Citation: J. Kaern et al., CISPLATIN 5-FLUOROURACIL TREATMENT OF RECURRENT CERVICAL-CARCINOMA - A PHASE-II STUDY WITH LONG-TERM FOLLOW-UP/, Gynecologic oncology, 60(3), 1996, pp. 387-392

Authors: KRISTENSEN GB HOLM R ABELER VM TROPE CG
Citation: Gb. Kristensen et al., EVALUATION OF THE PROGNOSTIC-SIGNIFICANCE OF CATHEPSIN-D, EPIDERMAL GROWTH-FACTOR RECEPTOR, AND C-ERBB-2 IN EARLY CERVICAL SQUAMOUS-CELL CARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY, Cancer, 78(3), 1996, pp. 433-440

Authors: HAGMAR B CHRISTENSEN JJP JOHANSSON B KALANTARI M RYD W SKYLDBERG B WALAAS L WARLEBY B KRISTENSEN GB
Citation: B. Hagmar et al., IMPLICATIONS OF HUMAN PAPILLOMAVIRUS TYPE FOR SURVIVAL IN CERVICAL SQUAMOUS-CELL CARCINOMA, International journal of gynecological cancer, 5(5), 1995, pp. 341-345

Authors: KRISTENSEN GB BAEKELANDT M VERGOTE IB TROPE C
Citation: Gb. Kristensen et al., A PHASE-II STUDY OF CARBOPLATIN AND HEXAMETHYLMELAMINE AS INDUCTION CHEMOTHERAPY IN ADVANCED OVARIAN-CARCINOMA (AOC), European journal of cancer, 31A, 1995, pp. 505-505

Authors: KRISTENSEN GB HOLM R ABELER VM TROPE CG
Citation: Gb. Kristensen et al., THE PROGNOSTIC-SIGNIFICANCE OF NM23, CATHEPSIN-D, EGFR AND C-ERBB-2 IN CERVICAL-CANCER, European journal of cancer, 31A, 1995, pp. 1184-1184

Authors: KRISTENSEN GB BAEKELANDT M VERGOTE IB TROPE C
Citation: Gb. Kristensen et al., A PHASE-II STUDY OF CARBOPLATIN AND HEXAMETHYLMELAMINE AS INDUCTION CHEMOTHERAPY IN ADVANCED EPITHELIAL OVARIAN-CARCINOMA, European journal of cancer, 31A(11), 1995, pp. 1778-1780

Authors: NORDAL RR KRISTENSEN GB KAERN J STENWIG AE PETTERSEN EO TROPE CG
Citation: Rr. Nordal et al., THE PROGNOSTIC-SIGNIFICANCE OF STAGE, TUMOR SIZE, CELLULAR ATYPIA ANDDNA-PLOIDY IN UTERINE LEIOMYOSARCOMA, Acta oncologica, 34(6), 1995, pp. 797-802

Authors: KRISTENSEN GB KAERN J ABELER VM HAGMAR B TROPE CG PETTERSEN EO
Citation: Gb. Kristensen et al., NO PROGNOSTIC IMPACT OF FLOW-CYTOMETRIC MEASURED DNA-PLOIDY AND S-PHASE FRACTION IN CANCER OF THE UTERINE CERVIX - A PROSPECTIVE-STUDY OF 465 PATIENTS, Gynecologic oncology, 57(1), 1995, pp. 79-85

Authors: MAKAR AP BAEKELANDT M TROPE CG KRISTENSEN GB
Citation: Ap. Makar et al., THE PROGNOSTIC-SIGNIFICANCE OF RESIDUAL DISEASE, FIGO SUBSTAGE, TUMORHISTOLOGY, AND GRADE IN PATIENTS WITH FIGO STAGE-III OVARIAN-CANCER, Gynecologic oncology, 56(2), 1995, pp. 175-180

Authors: SCHEISTROEN M TROPE C KOERN J PETTERSEN EO ABELER VM KRISTENSEN GB
Citation: M. Scheistroen et al., MALIGNANT-MELANOMA OF THE VULVA - EVALUATION OF PROGNOSTIC FACTORS WITH EMPHASIS ON DNA-PLOIDY IN 75 PATIENTS, Cancer, 75(1), 1995, pp. 72-80

Authors: MAKAR AP HOLM R KRISTENSEN GB NESLAND JM TROPE CG
Citation: Ap. Makar et al., THE EXPRESSION OF C-ERBB-2 (HER-2 NEU) ONCOGENE IN INVASIVE OVARIAN MALIGNANCIES/, International journal of gynecological cancer, 4(3), 1994, pp. 194-199

Authors: DORUM A KRISTENSEN GB TROPE C
Citation: A. Dorum et al., RANDOMIZED STUDY OF CISPLATIN VERSUS THIOTEPA AS INDUCTION CHEMOTHERAPY IN ADVANCED OVARIAN-CARCINOMA, European journal of cancer, 30A(10), 1994, pp. 1470-1474
Risultati: 1-25 | 26-32